Celltrion USA Announces FDA Approval of ZYMFENTRA^® for the Treatment of People with Inflammatory Bowel Disease

ZYMFENTRA® for maintenance therapy in adults with moderately to severely active ulcerative colitis and Crohn’s disease following treatment with an infliximab product administered intravenously.